Fluorodeoxyglucose versus Non-Fluorodeoxyglucose PET-Computed Tomography in Less-Explored Domains: An Appraisal - 16/06/22
Doi : 10.1016/j.cpet.2022.05.001
Sandip Basu, MBBS, DRM, DNB, MNAMS 
Radiation Medicine Centre (B.A.R.C.), Tata Memorial Hospital Annexe, Jerbai Wadia Road, Parel, Mumbai 400012, India
Homi Bhabha National Institute, Mumbai, Maharashtra, India
Rakesh Kumar, MBBS, DRM, DNB, MNAMS, PhD
Division of Diagnostic Nuclear Medicine, Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110029, India
Abass Alavi, MD, MD (Hon), PhD (Hon), DSc (Hon)
Division of Nuclear Medicine, Department of Radiology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
El texto completo de este artículo está disponible en PDF.
© 2022
Publicado por Elsevier Masson SAS.
Vol 17 - N° 3
P. xv-xvi - juillet 2022 Regresar al número
Artículo precedente
- CME Accreditation Page
- Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors : It Is Time to Rectify the Ongoing Misconceptions
- Nadia Withofs, Rakesh Kumar, Abass Alavi, Roland Hustinx
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?